Ivantist Treats Glaucoma
Ivantis Microstent Technology
Ivantis MicroStent News & Events

The Hydrus Microstent Ivantis HYDRUS IV United States Clinical Trial

Contact Ivantis Microstent Developers

Dave Van Meter, Chairman, President, and Chief Executive Officer

Dave joined Ivantis as President and CEO in January 2008. Prior to joining Ivantis, Dave held various positions of increasing responsibility in Marketing and General Management throughout his career, most recently at Abbott Vascular, where he began in August 2001...

read more

Randy Alexander, Independent Board Member

Randy is the Chairman of the Board of Directors of ReVision Optics™, Inc. and a seasoned senior executive and leader in the ophthalmic industry...

read more

Ali Behbahani, MD, New Enterprise Associates, Special Partner

Ali joined NEA in 2007 and is a Partner on the healthcare team. He specializes in investments in the biopharmaceutical, medical device, specialty pharmaceutical and healthcare services sectors.

read more

Tara Butler M.D., Ascension Health Ventures

Tara Butler joined AHV in 2002 after completing a residency in obstetrics and gynecology at Washington University in St. Louis. She primarily focuses on...

read more

Jay Graf, New Enterprise Associates, Venture Partner

Jay joined NEA in October 2005 as a Venture Partner focusing primarily on medical device investments. Jay comes to NEA after nearly 30 years experience in the healthcare industry...

read more

Ben Gust, GBS Venture Partners

Ben Gust BSc, LLB, GDipAppFin, GAICD joined GBS in 2003 following several years in the legal industry practising as a Solicitor and managing international litigation...

read more

Thong-Yuen Poon, Ph.D., Vice President (Investments) at EDB Investments

Thong-Yuen is a Vice President (investments) of EDB Investments (EDBI), the corporate venture arm of the Singapore Economic Development Board. He is currently part of the Life-sciences Group. Previously, he was Head of the EDBI Boston Center and...

read more

Doug Roeder, Delphi Ventures, General Partner

Doug joined Delphi Ventures as an Associate in 1998 and became a Partner in 2000. His primary investment focus at Delphi is on medical devices and diagnostics...

read more

Christopher Shen, MD, Vertex Management

Christopher Shen, MD is a Managing Director and head of U.S. healthcare investing at Vertex Management. Dr. Shen specializes in investments in biopharmaceutical and medical device companies. Previously, Dr. Shen worked at Essex Woodlands Health Ventures, a healthcare-focused venture capital and private equity firm...

read more